Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine.

Nutirakendus aitab luua kontakti arstide ja HIV positiivsete inimeste vahel. Nutirakendus aitab mugavalt organiseerida ravimite võtmise aegu, seadistada ainult Teile arusaadavad ja personaalseid meeldetuletusi, võimaldab saada arstilt tagasisidet ning panna aega vastuvõtule või analüüsidele.

Kõik uudised / Oktoober 2017

Arhiiv

✕

10 oktoober 2017

3597

The International AIDS Society mourns the passing of Amsterdam Mayor

The International AIDS Society mourns the passing of Amsterdam Mayor

“To stop the urban HIV epidemic, inclusivity is essential,” Mayor van der Laan said. His leadership vividly reflected this commitment to an open, transparent and participatory fight against HIV.

10 oktoober 2017

3937

Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

Despite remarkable gains in the treatment and prevention of HIV infection, development of an effective HIV vaccine likely will be necessary to achieve a durable end to the HIV/AIDS pandemic, according to a new commentary from Anthony S. Fauci, M.D., director of NIAID.

10 oktoober 2017

3900

California lowers penalty for knowingly exposing partners to HIV

California lowers penalty for knowingly exposing partners to HIV

The law previously punished people who knowingly exposed or infected others with HIV by up to eight years in prison. This new legislation will lower jail time to a maximum of six months.

9 oktoober 2017

3618

Many MSM currently taking PrEP would switch to injectable forms of the therapy

Many MSM currently taking PrEP would switch to injectable forms of the therapy

Approximately a third of gay and bisexual men who are currently taking oral pre-exposure prophylaxis would prefer long-acting injectable PrEP should it become available.

9 oktoober 2017

3592

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab

Theratechnologies Inc. today announced 48-week efficacy and safety results for ibalizumab in patients infected with multidrug resistant HIV-1.

9 oktoober 2017

4736

Gay Men May Be Able to Self-Check for Anal Cancer

Gay Men May Be Able to Self-Check for Anal Cancer

A recent study found that self- and partner exams were a fairly reliable way of identifying anal abnormalities that may be signs of cancer.

9 oktoober 2017

3793

ART Limits Appropriate Contraceptive Options for Women with HIV

ART Limits Appropriate Contraceptive Options for Women with HIV

Hormonal contraceptives with potential drug-drug interactions with antiretroviral therapy are commonly prescribed to women living with HIV, according to retrospective study findings.

8 oktoober 2017

3959

How UNAIDS “90-90-90” target looks in Russia today

How UNAIDS “90-90-90” target looks in Russia today

According to the Federal AIDS Center estimates, the UNAIDS "90-90-90" target in Russia looks like "64-33-75".

6 oktoober 2017

3203

Electronic systems in healthcare improve adherence to HIV treatment

Electronic systems in healthcare improve adherence to HIV treatment

Electronic systems in healthcare (e. g. mobile apps or websites) have a number of positive effects to people living with HIV

6 oktoober 2017

3357

Risk for Many Cancers Has Fallen for People With HIV

Risk for Many Cancers Has Fallen for People With HIV

Risk for Many Cancers Has Fallen for People With HIVSince the advent of effective combination antiretroviral treatment two decades ago, the risk of many cancers has fallen for people living with HIV. However, this population’s risk for a slew of cancers remains elevated ...

1 2 3 4 5